SOURCE: World Street Fundamentals

May 13, 2011 09:00 ET

A Brighter Decade Ahead for Biotech - Equity Research on Discovery Laboratories and Mylan Inc.

HONG KONG--(Marketwire - May 13, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting Discovery Laboratories, Inc. (NASDAQ: DSCO) and Mylan Inc. (NASDAQ: MYL). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php.

Biotech is enabling creation of new drugs at a faster pace than the traditional pharmaceutical model and some believe that after a decade of mediocre performance it is approaching an inflection point. Companies are much more conducive to focusing on productivity and the sector is showing signs of being back to top growth by 2013 due to the opportunity emerging markets have created.

World Street Fundamentals has highlighted Discovery Laboratories for its focus on developing surfactant therapies to treat respiratory disorders and diseases. The Company's KL4 technology produces a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to pulmonary surfactant, a substance produced naturally in the lung and essential for survival and normal respiratory function.

In addition, its capillary aerosol-generating technology (capillary aerosolization technology) produces a dense aerosol with a defined particle size, to deliver its aerosolized KL4 surfactant to the lung. The Company is developing its products, Surfaxin (lucinactant), Surfaxin LS and Aerosurf, to address the respiratory conditions affecting pediatric populations. The entire report on Discovery Laboratories, Inc. (NASDAQ: DSCO) is available here: www.WorldStreetFundamentals.com/ViewFullReport.245.php.

World Street has highlighted Mylan for its wide customer base in more than 150 countries and territories. The Company operates in two segments: Generics and Specialty. Mylan is a fully-integrated global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients (API). The entire report on Mylan Inc. (NASDAQ: MYL) is available here: www.WorldStreetFundamentals.com/ViewFullReport.138.php.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets. Covering the top performers in the hottest sectors and providing clarity to investors around the world.

Contact Information